GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dominari Holdings Inc (NAS:DOMH) » Definitions » Cyclically Adjusted PB Ratio

Dominari Holdings (Dominari Holdings) Cyclically Adjusted PB Ratio : 0.01 (As of Jun. 03, 2024)


View and export this data going back to 1984. Start your Free Trial

What is Dominari Holdings Cyclically Adjusted PB Ratio?

As of today (2024-06-03), Dominari Holdings's current share price is $2.21. Dominari Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $441.99. Dominari Holdings's Cyclically Adjusted PB Ratio for today is 0.01.

The historical rank and industry rank for Dominari Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

DOMH' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.01   Max: 1.26
Current: 0.01

During the past years, Dominari Holdings's highest Cyclically Adjusted PB Ratio was 1.26. The lowest was 0.01. And the median was 0.01.

DOMH's Cyclically Adjusted PB Ratio is ranked better than
99.85% of 656 companies
in the Biotechnology industry
Industry Median: 1.745 vs DOMH: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dominari Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $8.032. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $441.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dominari Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Dominari Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dominari Holdings Cyclically Adjusted PB Ratio Chart

Dominari Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dominari Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.01

Competitive Comparison of Dominari Holdings's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Dominari Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dominari Holdings's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dominari Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dominari Holdings's Cyclically Adjusted PB Ratio falls into.



Dominari Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Dominari Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.21/441.99
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dominari Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Dominari Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8.032/131.7762*131.7762
=8.032

Current CPI (Mar. 2024) = 131.7762.

Dominari Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 3,066.897 100.560 4,018.954
201409 2,819.059 100.428 3,699.024
201412 2,571.305 99.070 3,420.186
201503 2,379.415 99.621 3,147.428
201506 446.545 100.684 584.443
201509 280.327 100.392 367.964
201512 248.933 99.792 328.717
201603 215.362 100.470 282.467
201606 162.542 101.688 210.636
201609 201.656 101.861 260.880
201612 77.714 101.863 100.536
201703 64.343 102.862 82.429
201706 36.651 103.349 46.732
201709 58.935 104.136 74.578
201712 47.578 104.011 60.279
201803 74.253 105.290 92.932
201806 71.490 106.317 88.610
201809 55.734 106.507 68.957
201812 102.317 105.998 127.200
201903 92.651 107.251 113.838
201906 82.085 108.070 100.092
201909 56.243 108.329 68.416
201912 37.103 108.420 45.096
202003 17.095 108.902 20.686
202006 15.332 108.767 18.575
202009 14.219 109.815 17.063
202012 14.419 109.897 17.290
202103 19.818 111.754 23.369
202106 19.573 114.631 22.500
202109 19.558 115.734 22.269
202112 19.258 117.630 21.574
202203 18.096 121.301 19.659
202206 17.656 125.017 18.611
202209 15.923 125.227 16.756
202212 14.703 125.222 15.473
202303 14.525 127.348 15.030
202306 11.689 128.729 11.966
202309 11.040 129.860 11.203
202312 8.917 129.419 9.079
202403 8.032 131.776 8.032

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dominari Holdings  (NAS:DOMH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Dominari Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Dominari Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dominari Holdings (Dominari Holdings) Business Description

Traded in Other Exchanges
Address
One Rockefeller Plaza, 11th Floor, New York, NY, USA, 10020
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing a therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore, and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company is also developing an antiviral platform, in which the compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.
Executives
Kyle Michael Wool director 650 5TH AVE, 35TH FLOOR, NEW YORK NY 10019
Christopher Franklin Devall officer: Chief Operating Officer DOMINARI HOLDINGS INC., ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Anthony Hayes director, officer: Chief Executive Officer 1796 SHADY LANE, COLUMBIA SC 29206
George Way officer: Chief Financial Officer C/O DOMINARI HOLDINGS INC., 725 5TH AVENUE 23RD FLOOR, NEW YORK NY 10022
Soo Yu director ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Tim S Ledwick director 10200 INNOVATION DRIVE, SUITE 300, MILWAUKEE WI 53226
Gregory James Blattner director ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY 10020
Paul Lemire director ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Robert Frederick Dudley director ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Zanden Robert J Vander director 913 HIGH KNOLL WAY, TRAVELERS REST SC 29690
Eric Weisblum director 285 GRAND AVENUE, ENGLEWOOD NJ 07631
Howard E Goldberg director 781 THIRD AVENUE, KING OF PRUSSIA PA 194061409
Frank Reiner officer: Interim CFO 6430 ROCKLEDGE DRIVE, SUITE 503, BETHESDA MD 20817
Jeffrey Ballabon director 6430 ROCKLEDGE DRIVE, BETHESDA NY 20817
Richard Cohen officer: Chief Financial Officer C/O DUNE ENERGY, INC., TWO SHELL PLAZA, 777 WALKER STREET, SUITE 2300, HOUSTON TX 77002